Clinical Trial Update: Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating neoadjuvant bevacizumab plus chemotherapy with short-course radiotherapy for rectal cancer; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Shanghai Minimally Invasive Surgery Center | Conditions: Neoadjuvant Treatment, Rectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN